Scarica l'app Stockscreener
22.53
0.09%
0.02
Dopo l'orario di chiusura:
22.53
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché CSTL Giù?
Forum
Previsione
Precedente Chiudi:
$22.51
Aprire:
$22.75
Volume 24 ore:
240.01K
Relative Volume:
0.52
Capitalizzazione di mercato:
$653.56M
Reddito:
$219.79M
Utile/perdita netta:
$-57.47M
Rapporto P/E:
-10.48
EPS:
-2.15
Flusso di cassa netto:
$-19.25M
1 W Prestazione:
-4.78%
1M Prestazione:
+3.59%
6M Prestazione:
+5.97%
1 anno Prestazione:
-33.28%
Intervallo 1D:
$22.31
$23.18
Intervallo di 1 settimana:
$22.11
$23.94
Portata 52W:
$14.59
$35.84
Castle Biosciences Inc Stock (CSTL) Company Profile
Nome
Castle Biosciences Inc
Settore
Industria
Telefono
866-788-9007
Indirizzo
505 S FRIENDSWOOD DRIVE, FRIENDSWOOD, TX
Confronta CSTL con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CSTL
Castle Biosciences Inc
|
22.53 | 648.63M | 219.79M | -57.47M | -19.25M | -2.15 |
|
TMO
Thermo Fisher Scientific Inc
|
536.78 | 198.56B | 43.21B | 6.58B | 6.17B | 17.28 |
|
DHR
Danaher Corp
|
210.92 | 147.61B | 24.01B | 3.41B | 4.86B | 4.7082 |
|
IDXX
Idexx Laboratories Inc
|
637.34 | 50.96B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
141.10 | 39.13B | 6.79B | 1.22B | 1.09B | 4.2644 |
|
IQV
Iqvia Holdings Inc
|
205.75 | 34.81B | 15.70B | 1.24B | 2.01B | 6.9036 |
Castle Biosciences Inc Stock (CSTL) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2023-12-14 | Iniziato | Guggenheim | Buy |
| 2023-01-05 | Iniziato | Scotiabank | Sector Outperform |
| 2022-01-07 | Iniziato | Stephens | Overweight |
| 2021-04-30 | Iniziato | Lake Street | Buy |
| 2020-11-10 | Iniziato | KeyBanc Capital Markets | Overweight |
| 2019-12-27 | Reiterato | Canaccord Genuity | Buy |
| 2019-08-19 | Iniziato | BTIG Research | Buy |
| 2019-08-19 | Iniziato | Canaccord Genuity | Buy |
| 2019-08-19 | Iniziato | Robert W. Baird | Outperform |
| 2019-08-19 | Iniziato | SVB Leerink | Outperform |
Mostra tutto
Castle Biosciences Inc Borsa (CSTL) Ultime notizie
Dimensional Fund Advisors LP Increases Stake in Castle Biosciences Inc. - GuruFocus
Momentum divergence signals in Castle Biosciences Inc. chartWeekly Trade Report & Weekly Hot Stock Watchlists - newser.com
Can swing trading help recover from Castle Biosciences Inc. lossesMarket Risk Report & Free Reliable Trade Execution Plans - newser.com
How high can Castle Biosciences Inc. stock goQuarterly Trade Summary & Real-Time Sentiment Analysis - newser.com
When is the best time to exit Castle Biosciences Inc.July 2025 Chart Watch & Low Drawdown Investment Ideas - newser.com
Is Castle Biosciences Inc. stock attractive for income investors2025 Year in Review & Reliable Entry Point Trade Alerts - newser.com
Risk adjusted return profile for Castle Biosciences Inc. analyzedEntry Point & AI Powered Market Entry Ideas - newser.com
Using data tools to time your Castle Biosciences Inc. exitWeekly Investment Recap & Free AI Powered Buy and Sell Recommendations - newser.com
Castle Biosciences to Release Third Quarter 2025 Financial - GlobeNewswire
Will Castle Biosciences Inc. stock remain a Wall Street favoriteWeekly Profit Analysis & Stock Portfolio Risk Management - newser.com
Castle Biosciences, Inc. to Announce Third Quarter 2025 Financial Results on November 3 - Quiver Quantitative
Nov. 3 webcast: Castle Biosciences to release Q3 results and host conference call at 4:30 PM ET - Stock Titan
Castle Biosciences to Release Third Quarter 2025 Financial Results and Host Conference Call on Monday, Nov. 3, 2025 - Sahm
New Data Demonstrates Significant & Risk-Appropriate Clinical Impact of DecisionDx-SCC Test Results on Patient Management Dec... - ADVFN
Is Castle Biosciences Inc. stock poised for growthDividend Hike & Proven Capital Preservation Tips - newser.com
Is this a good reentry point in Castle Biosciences Inc.July 2025 PostEarnings & Consistent Return Investment Signals - newser.com
What drives Castle Biosciences Inc stock priceCup and Handle Formations & Free Expert Stock Watchlists - earlytimes.in
How to integrate Castle Biosciences Inc. into portfolio analysis toolsMarket Performance Summary & Stepwise Entry/Exit Trade Alerts - newser.com
Weiss Ratings Reiterates "Sell (E+)" Rating for Castle Biosciences (NASDAQ:CSTL) - MarketBeat
Castle Biosciences Forms Golden Cross, Signaling Potential Bullish Breakout - Markets Mojo
Castle Biosciences CEO Maetzold sells $30,234 in shares - Investing.com
Will Castle Biosciences Inc. stock pay special dividendsGDP Growth & Weekly Top Gainers Trade List - newser.com
How Castle Biosciences Inc. stock reacts to Fed rate cuts2025 Price Action Summary & Weekly Market Pulse Alerts - newser.com
Order flow analysis tools used on Castle Biosciences Inc.2025 Pullback Review & Daily Stock Trend Reports - newser.com
Analyzing net buyer seller activity in Castle Biosciences Inc.Trade Volume Summary & Verified Technical Trade Signals - newser.com
Is Castle Biosciences Inc a good long term investmentBollinger Bands Signals & Low Risk Investment Growth - earlytimes.in
Castle Biosciences’ Founder, President and CEO Derek Maetzold Honored with the CEO of the Year Award by The CEO Magazine - The Manila Times
Castle Biosciences’ Founder, President and CEO Derek - GlobeNewswire
Selected from 586 Executives: Castle Biosciences' Derek Maetzold Crowned CEO of the Year 2025 - Stock Titan
User - FinancialContent
Castle Biosciences, Inc. (NASDAQ:CSTL) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Castle Biosciences Inc Azioni (CSTL) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.74%
0.28%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):